Q2
AUPH — Q2 2026 Financial Report Analysis
LUPKYNIS sales rose 19% to $79.4M and diluted EPS rose 75% to $0.28, though about half the doubling in operating income came from a Swiss-franc currency swing and one-off liability releases; 2026 guidance of $305–315M product sales reiterated.